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endovascular abdominal aortic aneurysm repair
Matthew P. Sweet, Mark F. Fillinger, Tina M. Morrison, Dorothy Abel
Objectives: The purpose of this study was to compare the eligibility of men
and women with infrarenal abdominal aortic aneurysms (AAAs) for on-label
endovascular aneurysm repair (EVAR) as part of the clinician-Food & Drug
Administration (FDA) collaborative effort, the Characterization of Human
Aortic Anatomy Project (CHAP).
Methods: Computed tomography (CT) scans with 3D reconstruction from
a single institution obtained between July 1996 and December 2009,
including standardized measurements by a blinded third-party (M2S, West
Lebanon, NH) were examined. For inclusion, abdominal aortic aneurysm
(AAA) had to be infrarenal, unrepaired, and >5 cm, or 4 cm to 5 cm if the
orthogonal sac diameter was more than twice the aortic diameter at the
renal level. Scans were included regardless of subsequent EVAR, open repair,
or lack of treatment. One thousand sixty-three unique, unrepaired AAAs
were analyzed.
Results: Neck length, diameter, and angulation differ for women (P < .001)
even after adjustment for patient age and AAA size. EVAR eligibility based on
device Instructions for Use (IFU) criterion is affected by gender. Neck length
<15 mm was found in 47% of men and 63% of women. Neck angulation
exceeding 60 degrees was found in 12% of men and 26% of women. Minimum
iliac diameter of 6 mm was found in 35% of men and 55% of women. Only 32%
of men and 12% of women met all three neck criterion and had iliac lumen
diameters >6 mm. Logistic regression modeling shows that older patient
age (odds ratio [OR], 0.84 per decade), increased aneurysm diameter (OR,
0.70 per cm), and female gender (OR, 0.4) are each independently associ-
ated with decreased odds of meeting all device IFU neck criterion (P <
.05). EVAR eligibility by neck criterion does not decline significantly until
AAA size exceeds 5.5 cm in women and 6.5 cm in men.
Conclusion: Women are significantly less likely to meet device IFU criterion
for EVAR. Aortic neck criteria and iliac access are important for men and
women, but more women than men fail to meet IFU criterion. Devices
that accommodate shorter infrarenal AAA neck length will have the greatest
impact on expanding on-label EVAR regardless of gender. Lower profile
devices and those that accommodate higher neck angulation are expected
to expand EVAR eligibility further for women. EVAR eligibility is unlikely to
be lost as AAAs enlarge to 5.5 cm in women and 6.5 cm in men. Observation
of small AAAs until they reach the standard threshold size for repair should
not compromise EVAR eligibility.Comparable mortality with open repair of complex and infrarenal aortic
aneurysm
Virendra I. Patel, Robert T. Lancaster, Mark F. Conrad, Glenn M. LaMuraglia,
Christopher J. Kwolek, David C. Brewster, Richard P. Cambria
Background: A consequence of endovascular aneurysm repair (EVAR) of
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for complex anatomy. Complex aneurysm repair with visceral vessel involve-
ment (CAA) or combined aneurysm repair and visceral vessel reconstruction
(VVR) has traditionally been considered to increase morbidity and mortality
compared with repair of infrarenal AAA. This study evaluated contemporary
outcomes of open abdominal aneurysm surgery, including AAA, CAA, and VVR
using the National Surgical Quality Improve Project (NSQIP) database.
Methods: The NSQIP Participant Use File was queried by CPT code to identify
patients undergoing AAA, CAA, and VVR (2005-2008). Comparative analysis of
clinical features, technical details and 30-day outcomes was performed
using univariate methods. Logistic regression analysis was used to identify
predictors of morbidity and mortality.
Results: A total of 2820 patients underwent AAA and 592 CAA. Renal insuf-
ficiency (ie, creatinine >1.4 mg/dL) rates were similar in AAA and CAA
patients, however, more frequent in patients with VVR (51% vs 31% [no
bypass]; P < .01). CAA was less likely to be performed urgently (6.3% vs
9.1%; P < .05) and was associated with increased operative time (254 
100 vs 224  93; P < .01) compared with AAA. Univariate analysis showed
that CAA did not increase mortality (5.7% vs 5.1%; P = .5). CAA slightly
increased overall complications (32% vs 27%; P = .01) compared with AAA.
73 (2.5%) AAA and 84 (12%) CAA patients had simultaneous VVR and these
patients exhibited a trend toward increased mortality (8.9% vs 5.2%; P =
.07). VVR increased complications (43% (VVR) vs 26% [no bypass]; P < .01),
including ventilation >48 hours (21% [VVR] vs 12% [no bypass]; P < .01), renal
failure (7.6% [VVR] vs 4.1% [no bypass]; P = .04), and sepsis (13% [VVR] vs
6.3% ([no bypass]; P < .01). Multivariate analysis demonstrated that CAA
(odds ratio [OR], 1.3 [95% confidence interval (CI), 1.1-1.6]; P = .01) and
VVR (OR, 2.2 [95% CI, 1.8-3.6]; P < .01) increased the odds of any complica-
tion. Independent predictors of mortality included dependent functional
status (OR, 3.6 [95% CI, 2.3-5.4]; P < .01), elevated pre-op creatinine (OR,
2.9 [95% CI, 2.2-4.0]; P < .01), type II diabetes (OR, 1.6 [95% CI, 1.05-2.4];
P = .03), and age (OR, 1.06 [95% CI, 1.03-1.08]; P < .01). Neither CAA (OR,
1.2 [95% CI, 0.84-1.8]; P = .3) nor VVR (OR, 1.6 [95% CI, 0.89-2.9]; P = .11)
were associated with increased mortality compared with AAA.
Conclusion: In contemporary practice the migration of open repair to
increasingly complex cases has been achieved with 30-day mortality essen-
tially equivalent to open repair of infrarenal AAA. Patients who require
VVR do sustain increased complications, in particular renal failure. These
data also emphasize the importance of baseline renal insufficiency in clinical
decision making. CAA and VVR are associated with increased morbidity in
comparison to AAA repair; however, both procedures can be safely per-
formed in patients without increased risk of operative mortality.Left subclavian artery coverage during thoracic endovascular aortic
repair and risk of perioperative stroke or death
Jayer Chung, Karthikeshwar Kasirajan, Ravi K. Veeraswamy, Thomas F.
Dodson, Atef A. Salam, Elliot L. Chaikof, Matthew A. Corriere
Introduction: Left subclavian artery (LSA) coverage during thoracic endo-
vascular aortic repair (TEVAR) is often necessary due to anatomic factors
and is performed in to up to 40% of procedures. Despite the frequency of
LSA coverage during TEVAR, reported associations with risk of
552 Abstractsperiprocedural stroke or death are inconsistent in reported literature. We
examined the 2005-2008 American College of Surgeons National Surgical
Quality Improvement Program Participant Use Data file to determine asso-
ciations between LSA coverage during TEVAR and risk of perioperative
stroke or death.
Methods: Current procedural terminology (CPT) codes were used to identify
patients undergoing TEVAR, LSA coverage, and subclavian revascularization.
Patients undergoing coronary bypass, ascending aortic repair, abdominal
aortic aneurysm repair, or nonvascular intra-abdominal procedures during
the same operation were excluded. Perioperative stroke and mortality asso-
ciations with LSA coverage were examined using logistic regression models
for each outcome. Significance was assessed at a = 0.05, with univariable
P < .05 required for multivariable model entry.
Results: Eight hundred forty-five TEVAR procedures were identified, of
which 52 patients were excluded due to additional major procedures per-
formed with TEVAR. Seven hundred thirty-three of the remaining 793 proce-
dures included CPT codes indicating primary placement of an initial thoracic
endograft and form the basis of this analysis. LSA coverage occurred in 279
procedures (38%). Thirty-day stroke and mortality rates were 5.7% and 7.0%,
respectively. LSA coverage was associated with increased 30-day risk of
stroke in multivariable modeling (odds ratio [OR], 2.17 95% confidence
interval [CI], 1.13-4.14; P = .019). Other significant multivariable risk factors
for stroke included proximal aortic cuff placement during TEVAR (OR, 2.58;
95% CI, 1.30-5.16; P = .007) and emergency procedure status (OR, 3.60; 95%
CI, 1.87-6.94; P < .001). No significant association between LSA coverage and
perioperative mortality was identified (univariable OR, 1.70; 95% CI, 0.98-
2.93; P = .0578).
Conclusion: LSA coverage during thoracic endovascular repair is associated
with increased risk of perioperative stroke following TEVAR. Further
evidence is needed to determine whether procedural modifications,
including LSA revascularization, reduce the incidence of stroke associated
with TEVAR.Short-term results of a randomized trial examining timing of carotid
endarterectomy in patients with severe asymptomatic unilateral carotid
stenosis undergoing coronary artery bypass grafting
Giulio Illuminati, Jean-Baptiste Ricco, Francesco Calio`, Maria Antonietta
Pacile`, Fabio Miraldi, Giacomo Frati, Francesco Macrina, Michele Toscano
Objective: This study evaluated the timing of carotid endarterectomy (CEA)
in the prevention of stroke in patients with asymptomatic carotid stenosis
>70% receiving a coronary artery bypass graft (CABG).
Methods: From January 2004 to December 2009, 185 patients with unilateral
asymptomatic carotid artery stenosis >70%, candidates for CABG, were
randomized into two groups. In group A, 94 patients received a CABG with
previous or simultaneous CEA. In group B, 91 patients underwent CABG, fol-
lowed by CEA. All patients underwent preoperative helical computed tomog-
raphy scans, excluding significant atheroma of the ascending aorta or aortic
arch. Baseline characteristics of the patients, type of coronary artery lesion,
and preoperative myocardial function were comparable in the two groups. In
group A, all patients underwent CEA under general anesthesia with the
systematic use of a carotid shunt, and 79 patients had a combined procedure
and 15 underwent CEA a few days before CABG. In group B, all patients
underwent CEA, 1 to 3 months after CABG, also under general anesthesia
and with systematic carotid shunting.
Results: Two patients (one in each group) died of cardiac failure in the post-
operative period. Operative mortality was 1.0% in group A and 1.1% in group
B (P = .98). No strokes occurred in group A vs seven ipsilateral ischemic
strokes in group B, including three immediate postoperative strokes and
four late strokes, at 39, 50, 58, and 66 days, after CABG. These late strokes
occurred in patients for whom CEA was further delayed due to an incomplete
sternal wound healing or because of completion of a cardiac rehabilitation
program. The 90-day stroke and death rate was 1.0% (one of 94) in group
A and 8.8% (eight of 91) in group B (odds ratio [OR], 0.11; 95% confidence
interval [CI], 0.01-0.91; P = .02). Logistic regression analysis showed that
only delayed CEA (OR, 14.2; 95% CI, 1.32-152.0; P = .03) and duration of
cardiopulmonary bypass (OR, 1.06; 95% CI, 1.02-1.11; P = .004) reliably pre-
dicted stroke or death at 90 days.
Conclusions: This study suggests that previous or simultaneous CEA in
patients with unilateral severe asymptomatic carotid stenosis undergoing
CABG could prevent stroke better than delayed CEA, without increasing
the overall surgical risk.Completion duplex ultrasound predicts early graft thrombosis after crural
bypass in patients with critical limb ischemia
Salvatore T. Scali, Adam W. Beck, Brian W. Nolan, David H. Stone, Randall R.
De Martino, Catherine K. Chang, Eva M. Rzucidlo, Daniel B. Walsh
Objective: To determine if intraoperative distal graft end-diastolic velocity
(EDV) using completion duplex ultrasound (CDU) predicts patency of crural
bypass in patients with critical limb ischemia (CLI).
Methods: Records of 116 non-consecutive patients who underwent crural
revascularization with vein conduit and CDU between 1998 and 2008 were
reviewed. Bypass grafts were performed for rest pain (34%) or tissue loss
(66%), while 56% of the reported cases were categorized as “disadvan-
taged” because of compromised vein quality or diseased arterial outflow.
A 10-MHz low-profile transducer was used to image the entire bypass at
case completion. Technical adequacy of the grafts was verified by
absence of retained valves, arteriovenous fistulas, or localized velocity
increases and presence of bypass-dependent distal pulses. Modified Ruth-
erford scores were calculated as surrogate markers of runoff resistance
and compared to distal graft EDV. The primary study end point was graft
patency during a 1-year posttreatment period. Patency rates were deter-
mined using Kaplan-Meier life table methodology and compared using the
log-rank test. Predictors of graft patency were determined by Cox propor-
tional hazards.
Results: Primary, primary-assisted, and secondary patency for all crural
bypasses were 62%, 66%, and 70% at 1 year, respectively. When stratified
by tertiles of distal graft EDV (0 - <5 cm/s, 5-15 cm/s, >15 cm/s), 1-year
primary patency rates were 32%, 64%, and 84% (P = .001). Low (0 - < 5
cm/s) distal graft EDV (hazard ratio [HR], 3.3 confidence interval [CI],
1.74-6.41; P < .001), poor-quality conduit (HR, 2.5; CI, 1.19-5.21; P =
.016), age <70 (HR, 2.08; CI, 1.06-4.00; P = .031), and lack of statin use
(HR, 2.04; CI, 1.04-4.00; P = .038) were independent predictors of graft
failure. While the modified Rutherford score correlated with distal graft
EDV (P = .05), it was not an independent predictor of patency (P = .58).
Predictors of low EDV (<5 cm/s) included single-vessel runoff (odds ratio
[OR], 3.33; CI, 1.14-9.71; P = .027), poor conduit (OR, 2.94; CI, 1.16-7.41;
P = 0.024), and diabetes (OR, 2.86; CI, 1.14-7.21; P = .025).
Conclusions: Distal graft EDV predicts crural vein graft patency in patients
with CLI. Grafts with EDV <5 cm/s remain at high risk for early failure. The
impacts on patency of statins, age, and poor-quality conduit are, again,
confirmed. These results highlight the value of EDV using intraoperative
CDU for anticipating and, possibly, improving results of open crural
revascularization.From the New England Society for Vascular Surgery
Utility of duplex ultrasound in detecting and grading de novo femoropo-
pliteal lesions
Sikandar Z. Khan, Muhammad A. Khan, Benjamin Bradley, Rajeev Dayal,
James F. McKinsey, Nicholas J. Morrissey
Background: Digital subtraction angiography (DSA) is the gold standard for
diagnosing lower extremity (LE) arterial lesions. However, duplex ultrasound
(DUS) is a widely used, safe, and noninvasive method of detecting LE
lesions. The purpose of this study was to establish DUS criteria for detecting
and grading de novo stenotic lesions in the femoropopliteal arterial
segment.
Methods: A prospective database was established including all patients who
underwent LE endovascular interventions between 2004 and 2009. Patients
with de novo stenotic lesions in the femoropopliteal segment were selected.
DUS and DSA data pairs 30 days apart were analyzed. Peak systolic velocity
(PSV; cm/s), velocity ratio (Vr), and DSA stenosis were noted. Linear regres-
sion and receiver operator characteristic (ROC) curves were used.
Results: Twohundred seventy-five lesions in 200 patients were analyzed. Indi-
cations were claudication (50.5%), rest pain (12.5%), and tissue loss (37.0%).
Mean time interval between DUS and DSA was 24 days. Both PSV (R = .80, R2
= .641; P<.001) and Vr (R = .73, R2 = .546; P<.001) showed strong correlation
with the degree of angiographic stenosis. ROC analysis showed that to detect
70% stenosis, a PSV of 200 cm/s had 89.2% sensitivity and 89.7% specificity,
and a Vr of 2.0 had 88.7% sensitivity and 90.2% specificity. Similarly, to differ-
entiate between<50% and50% stenosis, PSV of 150 cm/s and Vr of 1.5 were
highly specific and predictive. Combining PSV 200 cm/s and Vr 2.0 for 70%
stenosis gave 79.0% sensitivity, 99.0% specificity, 99.0% positive predictive
value, and 85.0% negative predictive value.
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accuracy in detecting femoropopliteal lesions. We propose DUS criteria of
PSV 200 cm/s and Vr 2.0 to differentiate between <70% and 70% de novo
stenosis in the femoropopliteal arterial segment.The application of infrared thermography in evaluation of patients at high
risk for lower extremity peripheral arterial disease
Chi-Lun Huang, Yen-Wen Wu, Chueh-Lung Hwang, Yuh-Shiun Jong, Chia-Lun
Chao, Wen-Jone Chen, Ying-Tai Wu, Wei-Shiung Yang
Objective: We investigated the usefulness of infrared thermography in eval-
uating patients at high risk for lower extremity peripheral arterial disease
(PAD), including severity, functional capacity, and quality of life.
Methods: A total of 51 patients (23 males; age 70  9.8 years) were
recruited. They completed three PAD-associated questionnaires, including
walking impairment, vascular quality of life, and 7-day physical activity
recall questionnaires before a 6-minute walking test (6MWT). Ankle-
brachial index (ABI) and segmental pressure were analyzed for PAD diag-
nosis and stenotic level assessment. The cutaneous temperature at shin
and sole were recorded by infrared thermography before and after the
walk test. Detailed demographic information and medication list were
obtained.
Results: Twenty-eight subjects had abnormal ABI (ABI <1), while PAD was
diagnosed in 20. No subjects had non-compressible artery (ABI >1.3). Demo-
graphic profiles and clinical parameters in PAD and non-PAD patients were
similar, except for age, smoking history, and hyperlipidemia. PAD patients
walked shorter distances (356  102 m vs 218  92 m; P < .001). Claudication
occurred in 14 patients, while seven failed in completing the 6MWT. The rest
temperatures were similar in PAD and non-PAD patients. However, the post-
exercise temperature dropped in the lower extremities with arterial
stenosis, but was maintained or elevated slightly in the extremities with
patent arteries (temperature changes at sole in PAD vs non-PAD patients:
1.25 vs 0.15C; P < .001). The exercise-induced temperature changes
at the sole were not only positively correlated with the 6MWD (Spearman
correlation coefficient = 0.31, P = .03), but was also correlated with ABI
(Spearman correlation coefficient = 0.48, P < .001) and 7-day physical
activity recall scores (Spearman correlation coefficient = 0.30, P = .033).
Conclusion: By detecting cutaneous temperature changes in the lower
extremities, infrared thermography offers another non-invasive, contrast-
free option in PAD evaluation and functional assessment.Stent graft treatment for hemodialysis access aneurysms
David Shemesh, Ilya Goldin, Ibrahim Zaghal, Daniel Berelowitz, Anthony G.
Verstandig, Oded Olsha
Background: Aneurysms that develop in arteriovenous accesses as a result of
repeated punctures are sometimes complicated by infection or ischemia
causing sloughing of the overlying skin, which may endanger the access
and risk major bleeding and other complications. Surgical revision may
necessitate the temporary use of a central venous catheter until dialysis
can be resumed via the access. We used stent grafts in selected patients
for the exclusion of access aneurysms.
Methods: Twenty of 63 patients requiring access revision for complication of
an aneurysm from February 2005 to December 2009 underwent ambulatory
endovascular stent graft deployment. Indications included signs of impend-
ing rupture, questionable viability of overlying skin, pain, infection, and
limitation of cannulation sites by the size or number of the aneurysms. Endo-
vascular treatment always included angioplasty of associated outflow or
central vein stenoses at the same ambulatory session.
Results: Twenty patients with complicated access aneurysms were treated by
endovascular stent graft exclusion at an average of 4.8 4.3 years (range, 0.2
to 16.1 years) after access construction: nine graft pseudoaneurysms, nine
native vein aneurysms, and two acute iatrogenic pseudoaneurysms. Six
patients had skin erosion over the aneurysm, and 12 had painful aneurysms
and clinical signs of compromised blood supply to the skin. Another two
patients with an acute giant false aneurysm occurring during endovascular
procedures were treated in the same interventional session by the stenting
technique to control bleeding. All the aneurysms underwent endovascular
exclusion without complications. Only one infected puncture site failed to
heal within 2 months of stenting and was closed surgically 10 months later
due to persistent localized graft infection, but with no further bleeding
episodes. Only one aneurysm did not reabsorb within 3 months. Patients with
painful skin ischemia had immediate pain relief. All patients also had stenosis
in the draining veins necessitating additional percutaneous transluminal angio-
plasty. Only one patient required hospitalization (for intravenous antibiotic
treatment of staphylococcal sepsis). No patients required a central catheter
for hemodialysis. One access occluded due to cephalic arch stenosis in a non-
compliant patient. Functional patency was 87% at 12 months, with a median
follow-up of 15 months (range, 6.3 to 55.5 months).
Conclusion: Endovascular treatment with stent grafts in complicated access
aneurysms is a simple, safe and rapid ambulatory procedure that enables
treatment of both the aneurysm and its accompanying draining vein
stenosis. It enables continued cannulation of the existing access and avoids
the use of central catheters.
